Bladder transplantation: the new frontier in abdominal organ transplantation / Transplante de bexiga: a nova fronteira no transplante de órgãos abdominais

ABSTRACT Lower urinary tract abnormalities are directly implicated in the etiology of renal dysfunction in 6 to 24% of dialytic patients. These patients require bladder capacity and compliance readjustment before being considered viable candidates for renal transplantation. Vesical augmentation surgeries often involve the use of intestinal segments. Although these procedures can effectively restore bladder capacity and compliance, they present various issues related to maintaining mucous absorption and secretion capacity. Acidosis, recurrent urinary tract infections, and stone formation are extremely common, leading to frequent hospitalizations and graft function loss. Urinary tissue is certainly ideal for these reconstructions; however, bladder augmentation using ureter and renal pelvis are feasible only in a minority of cases. Experimental studies have been conducted to establish the groundwork for vascularized bladder transplantation. Last year, for the first time, this procedure was performed on a brain-dead patient. During this intervention, cystectomy was performed with preservation the vascular pedicle, followed by organ reimplantation. The graft remained viable for a period of 12 hours post-transplant. However, this intervention utilized a robotic platform, making it less reproducible in a multi-organ procurement setting as well as for most transplant centers. Moreover, it is debatable whether the benefits of exclusive bladder transplantation outweigh the risks associated with immunosuppression. For patients needing renal transplantation and requiring lower urinary tract reconstruction, however, utilizing the donor's bladder may offer an attractive alternative, avoiding the inherent complications of enterocystoplasty without increasing immunological risk. Combined kidney and bladder transplantation has the potential to emerge as the next frontier in abdominal organ transplants.

RESUMO As alterações do trato urinário inferior estão diretamente implicadas na etiologia da disfunção renal em 6 a 24% dos pacientes em diálise. Esses pacientes necessitam readequação da capacidade e complacência vesical antes de serem considerados candidatos viáveis para o transplante renal. As cirurgias de ampliação vesical frequentemente envolvem a utilização de segmentos intestinais. Embora estes procedimentos possam reestabelecer de forma eficaz a capacidade e complacência vesical, apresentam diversos problemas relacionados à manutenção da capacidade de absorção e secreção de muco. Acidose, infecções urinárias de repetição e formação de cálculos são extremamente comuns levando a internações frequentes e perda de função do enxerto. O tecido urinário é certamente ideal para estas reconstruções, contudo, ampliações vesicais utilizando ureter e pelve renal são viáveis somente em uma minoria dos casos. Estudos experimentais têm sido conduzidos na busca de se estabelecer os fundamentos para um transplante vascularizado de bexiga. No ano passado, pela primeira vez, este procedimento foi realizado em um paciente em morte encefálica. Nessa intervenção, foi realizada a cistectomia, preservando-se o pedículo vascular, seguida pelo reimplante do órgão. Esse enxerto mostrou-se viável pelo período de 12 horas após o transplante. Entretanto, nesta intervenção, foi utilizada plataforma robótica tornando-o pouco reprodutível em um contexto de captação de múltiplos órgãos bem como para a maioria dos centros transplantadores. Além disso, é discutível se os benefícios do transplante vesical exclusivo compensam os riscos associados à imunossupressão. Para pacientes que precisam ser submetidos a transplante renal e requerem reconstrução do trato urinário inferior, entretanto, a utilização da bexiga do mesmo doador pode representar uma alternativa atraente, evitando as complicações inerentes às enterocistoplastias sem aumento do risco imunológico. O transplante combinado de rim e bexiga tem o potencial de se destacar como a próxima fronteira nos transplantes de órgãos abdominais.

Efecto de la pandemia en la cirugía radical del cáncer vesical / Effect of the pandemic on radical surgery for bladder cancer

Objetivo: El advenimiento de la pandemia de síndrome respiratorio agudo por coronavirus 2 (SARS-CoV-2) ha tenido un impacto en el manejo del resto de las patologías por la elevada presión asistencial generada. Por su historia natural, el cáncer vesical susceptible de cistectomía radical (CR) requiere especial atención. Nuestro objetivo es comparar los resultados perioperatorios y oncológicos de estos pacientes durante el estado de alarma respecto a la era pre-COVID en un centro de tercer nivel. Material y métodos: Estudio retrospectivo observacional descriptivo y analítico. Pacientes intervenidos de cistectomía radical por neoplasia entre abril de 2019 y marzo de 2021 divididos en dos grupos, abril 2019-marzo 2020 (n = 42) y abril 2020-marzo 2021 (n = 43). Resultados: Ambos grupos resultaron ser homogéneos. La mediana de espera desde la resección transuretral de vejiga hasta la realización de la CR no aumentó (82,5 vs. 83 días, p = = 0,860). No se observan tampoco diferencias en la estadificación TNM de las piezas quirúrgicas. Los tumores localmente avanzados no aumentaron significativamente (18 vs. 21, p = 0,580). La presencia de afectación ganglionar tampoco presentó diferencias significativas (10 vs. 13, p = 0,675). La estancia media disminuyó en un valor cercano a significación (mediana en días: 11 vs. 8, p = 0,056) sin que ello asociase un mayor número de complicaciones o de reingresos a los 30 días. Conclusión:: En nuestra serie no hemos constatado diferencias significativas en los resultados perioperatorios y oncológicos de pacientes tratados mediante CR durante la pandemia de COVID-19.

Introduction: The advent of the COVID-19 pandemic (caused by severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] has had an impact on the management of other pathologies due to the high healthcare pressure generated. Due to its natural history, bladder cancer amenable to radical cystectomy requires special attention. We aim to compare the perioperative and oncological results of these patients during the alarm state with respect to the pre-COVID era in a tertiary care center. Material and methods: Observational descriptive and analytical retrospective research. Patients who underwent radical cistectomy because of bladder cancer between April 2019 to March 2021, divided in two groups, April 2019-March 2020 (n = 42) and April 2020-March 2021 (n = 43). Results: Both groups turned out to be homogeneous. The median wait time from transurethral resection of the bladder to radical cystectomy did not increase (82.5 vs. 83 days, p = 0.860). No differences were observed in the TNM staging of the surgical specimens. Locally advanced tumors did not increase significantly (18 vs. 21, p = 0.580). The presence of lymph node involvement did not present significant differences either (10 vs. 13, p = 0.675). The average stay decreased by a value close to significance (median in days 11 vs. 8, p = 0.056) without being associated with a greater number of complications or readmissions at 30 days. Conclusion: In our series, we have not found significant differences in the perioperative and oncological results of patients treated by radical cystectomy during the COVID-19 pandem

Concordancia de la clasificación VI-RADS® y la patología en espécimen de cistectomía en un centro oncológico colombiano / Concordance of VI-RADS® classification and pathology in cystectomy specimen in a Colombian oncology center

Objetivo: El objetivo principal de este estudio es evaluar la concordancia del reporte de la clasificación Vesical Imaging-Reporting and Data System (VI-RADS®) en resonancia magnética (RM) y el reporte de patología del espécimen de cistectomía y definir si este estudio puede considerarse un estándar en el proceso de estadificación en el paciente con diagnóstico clínico de cáncer de vejiga. Método: Estudio analítico retrospectivo de corte transversal, se incluyeron 34 pacientes llevados a cistectomía radical o parcial a quienes se realizó RM multiparamétrica prequirúrgica y se realizó un estudio de concordancia entre la clasificación VI-RADS® y el resultado de patología. Todas las resonancias fueron leídas y revisadas por un único radiólogo institucional. Resultados: El estudio de concordancia como resultado principal mostró un área bajo la curva para VI-RADS® ≥ 4 y resultado patológico positivo para compromiso muscular de 0,84, con una sensibilidad del 89.3% y especificidad del 50%, demostrando la adecuada precisión diagnóstica de la prueba. Conclusiones: La clasificación VI-RADS® es una herramienta de diagnóstico caracterizada por un excelente rendimiento diagnóstico cuando se evalúa la concordancia con el reporte de la patología final en el espécimen de la cistectomía.

Objective: The main objective of this study is to assess the concordance of the magnetic resonance imaging (MRI) Vesical Imaging-Reporting and Data System (VI-RADS®) classification report and the pathology report of the cystectomy specimen and to define whether this study can be considered a standard in the staging process in patients with a diagnosis of bladder cancer. Method: Retrospective, cross-sectional analytical study that included 34 patients undergoing radical or partial cystectomy who underwent pre-surgical multiparametric MRI. A concordance study was performed between the VI-RADS® classification and the pathology result. All MRIs were read and reviewed by a single institutional radiologist. Results: The concordance study as the main result showed an area under the curve for VI-RADS® ≥ 4 and a positive pathological result for muscle involvement of 0.84, with a sensitivity of 89.3% and a specificity of 50%, demonstrating the adequate diagnostic accuracy of the test. Conclusions: The VI-RADS® classification is a diagnostic tool characterized by excellent diagnostic performance when evaluating the agreement with the final pathology report in the cystectomy specimen.

Manejo del cáncer de vejiga invasor de músculo con enfoque preservador de órgano: terapia trimodal / Management of muscle-invasive bladder cancer with an organ-sparing approach: trimodal therapy

El cáncer de vejiga es una patología frecuente del tracto genitourinario, cuyo tratamiento acarrea morbilidad y alteración de la calidad de vida y en particular en el subgrupo de pacientes con tumores vesicales clasificados como invasores de músculo. En los últimos años se han venido buscando alternativas terapéuticas para la cistectomía radical + linfadenectomía pélvica extendida, que es en la actualidad el estándar de manejo para los pacientes con carcinoma de vejiga invasor de músculo. Con el advenimiento de perfiles de manejo oncológico menos ablativos pero sin sacrificar resultados oncológicos y con las nuevas técnicas de radioterapia y quimioterapia, las modalidades terapéuticas preservadoras de órgano como la terapia trimodal (resección transuretral de tumor vesical + quimioterapia + radioterapia) se convierte en una alternativa terapéutica viable y con resultados oncológicos satisfactorios a largo plazo. Objetivo y metodología: Con esta revisión se pretende mostrar la actualidad de la terapia trimodal en el manejo de los tumores vesicales con invasión muscular, definir los mejores pacientes a considerar para recibir esta terapia, exponer los resultados oncológicos comparados con el estándar de manejo y los resultados en calidad de vida. También se propone un algoritmo de manejo y se presentar las recomendaciones al respecto en guías de práctica clínica. Conclusiones: La terapia trimodal es una alternativa al estándar de manejo que conduce a resultados oncológicos aceptables y puede considerarse una opción de tratamiento en pacientes bien seleccionados.

Introduction: Bladder cancer is a frequent pathology of the genitourinary tract, whose treatment causes morbidity and impaired quality of life, particularly in the subgroup of patients with bladder tumors classified as muscle invaders. In recent years, therapeutic alternatives have been sought for radical cystectomy + extended pelvic lymphadenectomy, which is currently the standard of care for patients with muscle-invasive bladder carcinoma. With the advent of less ablative oncological management profiles but without sacrificing oncological results and with new radiotherapy and chemotherapy techniques, organ-sparing therapeutic modalities such as trimodal therapy (transurethral resection of bladder tumor + chemotherapy + radiotherapy) becomes a viable therapeutic alternative with satisfactory long-term oncological results. Objective and methodology: This review aims to show the current status of trimodal therapy in the management of muscle-invasive bladder tumors, define the best patients to consider for receiving this therapy, present the oncological results compared with the management standard and the results in quality of life. A management algorithm is also proposed and recommendations in this regard are presented in clinical practice guidelines. Conclusions: Trimodal therapy is an alternative to standard management that leads to acceptable oncological outcomes and can be considered a treatment option in well-selected patients.

Diagnóstico y manejo multidisciplinario de endometriosis vesical: reporte de caso

La endometriosis vesical es una entidad médica poco frecuente, que se diagnostica mediante procedimientos clínicos y de imágenes. La ecografía transvaginal es la técnica de primera línea para el diagnóstico. Su tratamiento es laparoscópico, con buenos resultados. Presentamos el caso de una paciente con esta patología, con abordaje quirúrgico multidisciplinario y evolución satisfactoria en el control de la enfermedad.

Bladder endometriosis is a rare medical entity, diagnosed by clinical and imaging procedures. Transvaginal ultrasound is the first line technique for diagnosis. The treatment is laparoscopic, with good results. We present the case of a patient with this pathology, with multidisciplinary surgical approach and satisfactory evolution in the control of the disease.

Bovine tunica albuginea conserved in honey as xenograft for cystoplasty in rats / Túnica albugínea bovina conservada em mel como xenoenxerto na cistoplastia em ratos

ABSTRACT: Urinary bladder damages leading to few viable bladder tissue available might demand a challenging reconstructive surgery. In this context, biomaterials are valid alternatives for bladder reconstruction. This study evaluated the bovine tunica albuginea fragment as graft material for cystoplasty in rats and honey-preserved implant viability.Thirty Wistar rats were assigned to two groups: (1) a test group (T) with a circular 1.0-cm-diameterbovine tunica albuginea graft application in the apex region by a continuous absorbable (Polyglactin 910 5-0) suture with stitching of all bladder layers and (2) a simulation group (S) in which animals underwent only partial cystectomy. In addition, each of these groups was further divided into three subgroups according to euthanasia period on post-surgery day 7, 15 and 30.Two animals had self-limiting hematuria at postsurgical period. At necropsy, frequent crystals and adhesion to the peritoneum were observed. At the histopathological evaluation, animals from the T group euthanized by 15th postoperative day had layers disorganization and initial muscle development, while T group rats euthanized by 30th postoperative day showed complete urothelization. Urothelization pattern was similar in both groups. Moreover, the muscular layer formation was present in both groups, but more evident in S group animals. Nevertheless, inflammatory infiltrate and neovascularization were remarkably more intense in T group rats.It might be concluded that bovine tunica albuginea graft was successful in repairing rats' bladder, being a good biomaterial option in reconstructive urinary vesicle surgery.

RESUMO: Lesões na vesícula urinária que culminem em pouco tecido vesical viável podem demandar cirurgias reconstrutivas desafiadoras. Neste contexto, biomateriais são alternativas válidas para a reconstrução da bexiga. O objetivo deste trabalho foi avaliar a túnica albugínea bovina como material para enxerto na cistoplastia em ratos, assim como a viabilidade deste implante preservado em mel. Trinta ratos Wistar foram divididos em dois grupos: (1) um grupo teste (T), no qual os animais foram submetidos a cistectomia parcial seguida de cistoplastia com aplicação do enxerto circular com 1,0cm de diâmetro de túnica albugínea bovina na região do ápice com sutura absorvível (Poliglactina 910 5-0) em padrão contínuo englobando todas as camadas da bexiga; e (2) um grupo simulação (S), cujos ratos realizaram apenas cistectomia parcial. Além disso, cada grupo foi posteriormente dividido em três subgrupos de acordo com a data de eutanásia no dia 7, 15 ou 30 de pós-operatório.Dois animais apresentaram hematúria autolimitante no período de observação pós-operatória. Na necrópsia, notaram-se cristais frequentes e aderências entre bexiga e peritônio. Na avaliação histopatológica, animais do grupo T eutanasiados com 15 dias de pós-operatório apresentavam camadas vesicais desorganizadas e formação de musculatura inicial na bexiga, enquanto aqueles eutanasiados com 30 dias de cirurgia mostraram urotelização completa. O padrão de urotelização foi semelhante nos dois grupos. Além disso, a formação da camada muscular esteve presente em ambos os grupos, porém mais evidente nos animais do grupo S. No entanto, o infiltrado inflamatório bem como a neovascularização foram notavelmente mais intensos nos ratos do grupo T.Pode-se concluir que o enxerto de túnica albugínea bovina foi bem sucedido no reparo da vesícula urinária de ratos, demonstrando ser uma boa opção de biomaterial para cirurgias reconstrutivas da vesícula urinária.

Mortality after radical cystectomy is strongly related to the institution's volume of surgeries / Mortalidade pós-cistectomia radical está fortemente associada ao volume de cirurgias da instituição

ABSTRACT Objective: To analyze mortality rates and hospitalization data after radical cystectomy in each public healthcare center in São Paulo in the last decade, considering the number of surgeries performed at each center. Methods: This study included patients from the Departamento de Informática do Sistema Único de Saúde from the state of São Paulo, who underwent radical cystectomy between 2008 and 2018. Data analyzed included organization name, number of procedures/year, in-hospital death rates and hospital length of stay. Results: A total of 1,377 radical cystectomies were registered in the public health system in São Paulo, between 2008-2018. A total of 91 institutions performed at least one radical cystectomy in the decade analyzed. The number of radical cystectomies performed per organization during the years analyzed ranged from one to 161. Only 45.6% of patients were operated in organizations that performed more than five radical cystectomies yearly. A total of 684 patients were operated in organizations with higher surgical volume. There were 117 in-hospital deaths, representing an 8.5% mortality rate for the state of São Paulo during the last decade. Whereas highest volume organizations (>6 radical cystectomies/year) had a mortality rate of 6.1%, the lowest volume (<1 radical cystectomy /year) had a 17.5% in-hospital mortality rate. Conclusion: There was a strong relation between organization volume of radical cystectomy and in-hospital mortality rate after radical cystectomy in São Paulo from 2008-2018. Unfortunately, we could not observe a trend toward centralization of such complex procedures, as it has occurred in developed countries during the last decades.

RESUMO Objetivo: Analisar as taxas de mortalidade e os dados de hospitalização após cistectomia radical em cada unidade pública de saúde de São Paulo na última década, levando em conta o número de cirurgias realizadas por unidade. Métodos: Este estudo incluiu pacientes do Departamento de Informática do Sistema Único de Saúde de São Paulo submetidos à cistectomia radical entre 2008 e 2018. Os dados analisados incluíram o nome da instituição, o número de procedimentos/ano, taxas de mortalidade hospitalar e tempo de internação hospitalar. Resultados: Foram registrados 1.377 cistectomias radicais no sistema público de saúde de São Paulo no período. Um total de 91 instituições realizou pelo menos uma cirurgia na década analisada. O número de cistectomias realizadas por instituição durante os anos analisados variou de uma a 161. Apenas 45,6% dos pacientes foram operados em instituições com volume cirúrgico maior do que cinco cistectomias radicais/ano. Ao todo, 684 pacientes foram operados em instituições com maior volume cirúrgico. Houve 117 óbitos hospitalares, representando taxa de mortalidade de 8,5% para o estado de São Paulo na última década. Enquanto instituições com o maior volume (seis cistectomias radicais/ano) apresentaram mortalidade de 6,1%, as instituições com menor volume (<1 cistectomia radical/ano) apresentaram taxa de mortalidade de 17,5%. Conclusão: Houve forte relação entre o volume institucional de cistectomia radical e a taxa de mortalidade hospitalar após cistectomia radical em São Paulo, no período de 2008 a 2018. Infelizmente, não se observa no Brasil tendência de centralização de procedimentos complexos, como tem ocorrido em países desenvolvidos nas últimas décadas.

Enfoque multidisciplinario del cáncer de vejiga en Pinar del Río / A multidisciplinary approach to bladder cancer in Pinar del Rio province

RESUMEN Introducción: el cáncer de vejiga constituye la sexta causa de muerte en los hombres cubanos y la décima en las mujeres. Esta investigación ofrece un acercamiento a factores que se relacionan con el pronóstico de la enfermedad y el abordaje terapéutico en la provincia pinareña. Objetivo: caracterizar el cáncer de vejiga en pacientes atendidos en el Centro de Atención al Paciente Oncológico III Congreso de Pinar del Río entre noviembre 2013 a marzo 2017. Métodos: se trató de un estudio observacional, descriptivo y ambispectivo, de un universo de 60 casos de los que se tomó una muestra de pacientes que cumplieron con el diagnóstico histológico positivo e información suficiente contenida en las historias clínicas. Resultados: el cáncer de vejiga fue más frecuente en hombres de piel blanca y edad superior a 60 años. El hábito de fumar estuvo presente en el 32,6 % de los pacientes. El 75,47 % presentó tumores de alto e intermedio grado y el 28,5 % infiltración del espacio linfovascular. El 59,18 % de los pacientes presentó enfermedad músculo invasiva, recibiendo tratamiento quirúrgico basado en resección transuretral o cistectomía parcial el 80,64 %, de ellos recibieron tratamiento adyuvante con quimioterapia o radioterapia el 54,83 %. Los pacientes con enfermedad no músculo invasiva fueron tratados con resección transuretral o cistectomía parcial (83,1 %), el 44,3 % recibió tratamiento adyuvante con BCG. La supervivencia libre de enfermedad fue del 86,1 % y la media de 35,3 meses. Conclusiones: el cáncer de vejiga se presentó con factores pronósticos adversos requiriendo el empleo de tratamiento multimodal para su manejo.

ABSTRACT Introduction: bladder cancer is the sixth leading cause of death among Cuban men and the tenth leading cause of death among women. This research presents an approach to the factors related to the prognosis of the disease and the therapeutic method in Pinar del Río province. Objective: to characterize bladder cancer in patients treated at "III Congreso" Cancer Care Center in Pinar del Río province from November 2013 to March 2017. Methods: an observational, descriptive and ambispective study was conducted including 60 cases as a target group from which a sample of patients was taken who complied with the positive histological diagnosis and the information was collected from the medical records. Results: bladder cancer was more frequent in white-skinned men over 60 years of age. Smoking was present in 32,6 % of the patients; 75,47 % presented tumors of high and intermediate grade and 28,5 % having infiltration to the lymphovascular space; 59,18 % of the patients presented invasive muscle disease, receiving surgical treatment based on transurethral resection or partial cystectomy 80,64 %; adjuvant treatment with chemotherapy or radiotherapy was applied to 54,83 % of them. Patients with non-invasive muscle disease were treated with transurethral resection or partial cystectomy 83,1 %, where 54. 83 % underwent adjuvant treatment with BCG. Disease-free survival was 86,1 % and the mean 35,3 months. Conclusions: bladder cancer was presented with unfavorable prognostic factors requiring the use of multiple modalities of treatment for its management.

Manejo del Cáncer de Vejiga mediante cirugía convencional en Solca, experiencia 2012-2017 / Bladder Cancer Management through conventional surgery in Solca, experience 2012-2017

Introducción: El cáncer de vejiga es la más común de las patologías del tracto urinario. La importancia del estudio radica en el manejo quirúrgico de los pacientes con este tipo de neoplasias vesicales que en ciertos casos con diagnóstico temprano suelen ser curativo. La técnica quirúrgica empleada de acuerdo al tipo histológico de los pacientes con cáncer de vejiga de este reporte fue el objetivo principal de este estudio. Métodos: El presente es un estudio retrospectivo, fue realizado desde enero 2012 a julio 2017 en el que se revisaron las historias clínicas de los pacientes con diagnóstico de cáncer de vejiga atendidos en el Servicio de Urología Oncológica del Instituto Oncológico Nacional "Dr. Juan Tanca Marengo", Solca-Guayaquil. Se incluyeron pacientes operados dentro de la institución, con diagnóstico de cáncer de vejiga a quienes se les realizó Cistectomía radical más Bricker o Neovejiga. Se excluyeron pacientes con cáncer de vejiga oncológicamente no operables, casos clínicos con falta de información completa en la historia clínica, con exámenes diagnósticos incompletos. Se realizó un análisis estadístico descriptivo con porcentajes. Resultados: Ingresaron al estudio 89 casos, 53 (59.6 %) fueron hombres, 16 pacientes (18 %) con Cáncer de Vejiga de Bajo Grado Infiltrante a Lámina Propia (CABILAPRO), 1 paciente (1.1 %) con Cáncer de Vejiga de Bajo Grado Infiltrante a Muscular (CABIMUS), 5 pacientes (5.6 %) con Cáncer de Vejiga de Alto Grado Infiltrante a Lamina Propia (CALAPRO) y 63 pacientes (70.8 %) con Cáncer de Vejiga de Alto Grado Infiltrante a Muscular (CALMUS), Cáncer de Vejiga de Alto Grado Infiltrante a Grasa Perivesical 3 (3.4 %), de los cuales presentaron recidiva local pos tratamiento por CALMUS 13 (14.6 %), 1 rabdosarcoma. Tratamiento quirúrgico del CALMUS 18 cirugías con derivación Bricker y 7 Neo-vejigas orto tópicas. Se realizaron RTUv en 50 pacientes (56.2 %). Conclusión: La cirugía de cistectomía más derivación Bricker se realizó en menos de un cuarto de la población estudiada, la cirugía RTUv fue la más prevalente.

Introduction: Bladder cancer is the most common of the pathologies of the urinary tract. The importance of the study lies in the surgical management of patients with this type of bladder neoplasms that in certain cases with early diagnosis are usually curative. The surgical technique used according to the histological type of patients with bladder cancer in this report was the main objective of this study. Methods: This is a retrospective study, carried out from January 2012 to July 2017, in which the clinical histories of patients diagnosed with bladder cancer treated at the Oncology Urology Service of the National Oncological Institute "Dr. Juan Tanca Marengo ", Solca-Guayaquil. Patients operated on within the institution were included, with diagnosis of bladder cancer who underwent radical cystectomy plus Bricker or Neovejiga. Patients with oncologically inoperable bladder cancer were excluded, clinical cases with lack of complete information in the clinical history, with incomplete diagnostic tests. A descriptive statistical analysis was performed with percentages. Results: 89 cases were included in the study, 53 (59.6%) were men, 16 patients (18%) with Low-Grade Infiltrating Bladder Cancer (CABILAPRO), 1 patient (1.1%) with Low-grade Bladder Cancer Infiltrant to Muscular (CABIMUS), 5 patients (5.6%) with High-Grade Infiltrating Bladder Laminal Cancer (CALAPRO) and 63 patients (70.8%) with High-Grade Infiltrating Muscle Bladder Cancer (CALMUS), Cancer High Grade Infiltrant to Perivesical Fat Bladder 3 (3.4%), of which local recurrence after treatment by CALMUS 13 (14.6%), 1 rhabdosarcoma. Surgical treatment of CALMUS 18 surgeries Bricker and 7 Neo-bladders orthotopic. TURb was performed in 50 patients (56.2%). Conclusion: Bricker surgery was performed in less than a quarter of the study population, TURb surgery was the most prevalent.

Resultados oncológicos en pacientes con cáncer de vejiga pT0 posterior a cistectomía radical / Oncological outcomes of Patients with pT0 Bladder Cancer after Radical Cystectomy

Introducción: El estadío pT0 del cáncer de vejiga implica la ausencia de enfermedad en la pieza de cistectomía radical (CR). El objetivo de este estudio es describir los resultados oncológicos de los pacientes con estadío pT0 posterior a CR por carcinoma urotelial de vejiga. Materiales y métodos: Estudio retrospectivo de pacientes sometidos a CR por cáncer de vejiga, en una sola institución, sin neoadyuvancia, entre junio de 2005 y julio de 2013. Se incluyeron aquellos pacientes con diagnóstico histológico de estadío pT0 pN0. Se estimó la sobrevida global, sobrevida cáncer-específica y sobrevida libre de recidiva con el método de Kaplan-Meier. Resultados: De 254 pacientes cistectomizados, 17 presentaron estadío pT0 pN0 (6,7%). La mediana de edad fue 67 años (rango 49-85), 15 pacientes fueron hombres (88%). Los resultados patológicos posterior a resección transuretral de vejiga (RTUv) fueron 17% pT1 (n=3) y 83% pT2 (n=14). La mediana de tiempo entre RTUv y CR fue 60 días (rango 30- 95). Al 41% se le realizó derivación urinaria tipo Bricker y al 59%, una neovejiga. La mediana de estadía hospitalaria fue 8 días (rango 6-44). Se evidenció adenocarcinoma de próstata en 4 pacientes. La mediana de ganglios resecados fue 6 (rango 2-17). Ningún paciente recibió adyuvancia. La mediana de seguimiento fue 69 meses (rango 5-120). Un paciente presentó recidiva uretral a los 72 meses de la CR. La sobrevida cáncer-específica fue 100%, la sobrevida libre de recaída a 5 años fue 83,3% (intervalo de confianza [IC] de 95%: 53,5-100) y la sobrevida global a 5 años fue 82,4% (IC 95%: 64,7-100). Conclusión: El estadío pT0 del cáncer de vejiga presenta resultados oncológicos más favorables que los estadíos más avanzados. Sin embargo, la posibilidad de recurrencia existe, por lo que no se debe discontinuar el seguimiento de estos pacientes (AU)

Introduction: There are cases in which there is no evidence of disease in the radical cystectomy (RC) specimen (pT0 stage). The purpose of this study is to evaluate oncological outcomes of patients with pT0 bladder cancer after RC, in a single institution, without neo-adjuvant therapy. Materials and methods: Patients who underwent radical cystectomy from June 2005 to July 2013 were reviewed retrospectively. All patients had history of bladder urothelial carcinoma, treated with transurethral resection of the bladder (TURB) and confirmed with pathological analysis. Study variables included TURB pathology, time to RC, and pathologic features. Overall survival (OS), cancer-specific survival (CSS) and recurrence-free survival (RFS) were estimated. Results: RC was performed on 254 patients; 17 patients (6.7%) had pT0N0 stage. Median age was 67 years (range 49-85 years); 15 patients were male (88%). TURB pathology specimens were 17% pT1 (n=3), and 83% pT2 (n=14). Median time between TURB and RC was 60 days (range 30-95). Seven patients (41%) received an ileal conduit, and ten patients (59%) received a neobladder. Median hospital stay was eight days (range 6-44). Prostate adenocarcinoma was found in four (23%) patients. Median resected lymph nodes were six (range 2-17). No patients received adjuvant chemotherapy. Median follow-up was 69 months (range 5-120 months). One patient had a urethral relapse 72 months after RC. There was no cancer-specific mortality. RFS at 5 years was 83.3% (confidence interval [CI] 95%: 53.5-100); OS at 5 years was 82.4% (CI 95%: 64.7-100). Conclusion: pT0 stage after radical cystectomy shows more favorable oncologic outcomes than higher stages. However, cancer recurrence was found in a low number of patients, thus, patient follow-up should be maintained (AU)

Tipo de derivación urinaria en el paciente llevado a cistectomía radical, participación del urólogo y tasa de filtración de la anastomosis intestinal / Type of urinary diversion in the patient led to a radical cystectomy, participation of the urologist, and filtration rate of intestinal anastomosis

Objetivo Conocer la prevalencia de cistectomías radicales que se realizan en centros especializados en Colombia, definiendo tipo de derivación intestinal, participantes en su creación, segmento intestinal utilizado y tasa de filtración. Materiales y métodos Se realizó una encuesta a instituciones de salud colombianas que realizan cistectomías radicales de manera rutinaria, se analizaron variables como número de procedimientos por año, segmento intestinal utilizado, tipo de especialidad participante en la anastomosis intestinal y la tasa de filtración de esta. Resultados Quince instituciones colombianas respondieron la encuesta, el número de cistectomías realizadas por año fue: 5/15 (33,3%) más de 15 cirugías al año, 4/15(26,6%) entre 11 y 15 procedimientos al año, 3/15 (20%) entre 5 y 10 y otro 3/15 (20%) entre 1 y 5 cistectomías al año. El 93,3% de las instituciones realizan Bricker como derivación más común; solo una institución (6,7%) lleva a cabo ureterostomías cutáneas. Con respecto a los participantes en la creación de la anastomosis de las 14 instituciones, en 9 (64,2%) es realizada por cirujano general, en 4 (28,5%) la lleva a cabo un urólogo y en una (7,4%) la derivación es realizada por coloproctólogo. La gran mayoría de los centros tiene una incidencia baja de filtración intestinal. Conclusiones En la gran mayoría de las instituciones colombianas el cirujano general y en menor medida el urólogo participan en la creación de la anastomosis intestinal como parte del protocolo de la institución. La filtración es una complicación poco frecuente pero con alta morbimortalidad. Se requiere de entrenamiento por parte del urólogo en formación para lograr mejores resultados.

Objective To determine the prevalence of radical cystectomies that are performed in specialist centres in Colombia, defining the type of intestinal derivation, participants in its creation, intestinal segment used, and filtration rate. Materials and methods A survey was conducted in Colombian health institutions that routinely perform radical cystectomies. An analysis was made of the variables, such as number of procedures per year, intestinal segment used, specialty participating in the intestinal anastomosis, and the rate of filtration. Results A total of 15 health institutions responded to the survey. The number of cystectomies performed per year was; 5/15 (33.3%) with greater than 15 surgeries per year, 4/15 (26.6%) with between 11 and 15 procedures per year, 3/15 (20%) between 5­10/year, and another 3/15 (20%) between 1­5 cystectomies per year. Most (93.3%) of the institutions performed a Bricker as the most common derivation, with only one institution (6.7%) performing cutaneous ureterostomies. As regards the participants in the creation of the anastomosis of the 14 institutions, 9 (64.2%) were performed by a general surgeon, by a urologist in 4 (28.5%), and a coloproctologist performed the shunt in one (7.4%). The vast majority of centres have a low incidence of intestinal filtration. Conclusions In the great majority of Colombian institutions, the general surgeon, and to a lesser extent the urologist, participate in the creation of intestinal anastomosis as part of the protocol of the institution. Filtration is a rare complication, but with a high morbidity and mortality. Training by the urologist during training is required to achieve better results.

Cirugía Robótica en cáncer de vejiga músculo-invasor, una interrogante aún sin resolver / Robotic Surgery In Muscle-Invasive Bladder Cancer, An Unresolved Interrogant

INTRODUCCIÓN: La cirugía robótica es una técnica en aumento tanto en Chile como en el mundo. Una de las áreas de la medicina que ha sido pionera en la introducción de esta nueva técnica es Urología, dónde ha crecido el interés en torno a la utilización de la cirugía robótica en cáncer de vejiga músculo invasor(CVMI). El objetivo de esta revisión es examinar la bibliografía disponible sobre el tema. MÉTODOS: Se realizó una búsqueda no sistemática de la literatura utilizando la base de datos de Pubmed y MGH Treadwell library. En estas se utilizaron las palabras claves "Bladder cancer", Muscle-invasive bladder cancer", "Blader cancer epidemiology" , "Radical cistectomy" "Robot-assisted radical cistectomy", ¨Robotic surgery urology¨. Se aplicaron límites de publicaciones dentro de los últimos 10 años. DISCUSIÓN: El cáncer vesical es una enfermedad de alta prevalencia, aproximadamente el 25 % de ellos se presentan con CVMI al momento del diagnóstico. El tratamiento de estándar actualmente para CVMI la cistectomía radical con linfadenectomía pélvica extendida, derivación urinaria y quimioterapia neoadyuvante en ciertos casos. Buscando dar solución a las complicaciones de esta cirugía, surge el interés por utilizar la cirugía robótica en el tratamiento de CVMI a través de la cistectomía radical asistida por robot(CRAR). Actualmente se han publicado estudios con resultados que indican disminución de la morbilidad perioperatoria y menor estadía hospitalaria, manteniendo la eficacia oncológica de este procedimiento versus la cistectomía radical abierta(CRA). Otros estudios no han encontrado diferencias significativas entre las dos técnicas en cuanto a complicaciones. CONCLUSIÓN: Aún existe insuficiente experiencia y evidencia del uso de esta en cáncer de vejiga músculo-invasor pero los resultados actuales tienden a resultados no inferiores y positivos en cuanto a la CRAR versus la CRA.AU

METHODS: We performed a non-systematic literature search using the Pubmed and MGH Treadwell library database. Key words "Bladder cancer", Muscle-invasive bladder cancer", "Bladder cancer epidemiology" , "Radical cystectomy" "Robot-assisted radical cystectomy", ¨Robotic surgery urology¨. were used. Limits of publications were applied within the last 10 years. DISCUSSION: Bladder cancer is a highly prevalent disease. Approximately 25% of patients present with MIBC at the time of diagnosis. The standard treatment currently for CVMI is radical cystectomy with extended pelvic lymphadenectomy, urinary diversion and neoadjuvant chemotherapy in certain cases. In order to solve the complications of this surgery, there is an interest in the use of robotic surgery in the treatment of MIBC through robot assisted radical cystectomy (RARC). Studies with results indicating decreased perioperative morbidity and shorter hospital stay have been published, maintaining the oncological efficacy of this procedure versus open radical cystectomy (ORC). Other studies have found no significant difference between the two techniques in terms of complications. CONCLUSION: There is still insufficient experience and evidence of its use in m

Tropical spastic paraparesis - anesthetic approach / Paraparesia espástica tropical - abordagem anestésica

Abstract Introduction HTLV-1 infection is endemic in Japan, Caribbean, Africa, and South America. It is transmitted from mother to child, sexual contact, blood transfusions, or sharing needles. Tropical spastic paraparesis (TSP) is a chronic degenerative neurological disease associated with this infection. It results from a spinal cord symmetrical degeneration at the thoracic level and is characterized by progressive motor weakness in the lower limbs, hyperreflexia, sensitivity changes, urinary incontinence, and bladder dysfunction. Clinical case Female, 53 years old, HTLV-1 infection and TSP. She had decreased strength in the lower limbs and hyperreflexia, paretic gait, spasticity, and neurogenic bladder symptoms, with recurrent urinary infections. She was scheduled for cystectomy. The patient was monitored according to standard ASA. Due to severe coagulopathy and the possibility of neurological worsening, epidural catheter was not placed. The induction of general anesthesia was performed with midazolam and fentanyl, followed by etomidate and cisatracurium. She was intubated with a tube size seven and maintained with desflurane and oxygen. Anesthesia was uneventful; the surgery lasted 1 hour and 50 min. There were no complications in the immediate postoperative period, during hospitalization, nor deterioration of the neurological examination. The patient was discharged 20 days later. Discussion/Conclusion There are reports of decreased electromyographic response and neurological deterioration associated with propofol in these patients, etomidate was used. The hepatic metabolism of rocuronium posed a risk, we chose to use cistracurium. It was concluded that the anesthesia chosen did not affect the course of the disease.

Resumo Introdução A infecção por HTLV- 1 é endêmica no Japão, nas Caraíbas, na África e na América do Sul. A transmissão ocorre de mãe para filho, por contatos sexuais, transfusões de sangue ou partilha de agulhas. A essa infeção está associada uma doença neurológica degenerativa crônica, a paraparesia espástica tropical (TSP). Essa resulta de uma degeneração simétrica da espinal medula em nível torácico. Caracteriza-se por diminuição progressiva da força nos membros inferiores, hiperreflexia, alterações de sensibilidade, incontinência urinária e disfunção vesical. Caso clínico Mulher de 53 anos, infecção por HTLV-1 e TSP. Apresentava diminuição da força nos membros inferiores e hiperreflexia, tinha uma marcha parética, espasticidade e sintomas de bexiga neurogênica com infecções urinárias de repetição. Foi proposta para cistectomia. Foi monitorada de acordo com o padrão da ASA. Devido à coagulopatia grave e à possibilidade de agravamento neurológico, não se colocou cateter epidural. A indução da anestesia geral foi feita com midazolam e fentanil seguidos de etomidato e cisatracúrio. Foi entubada com um tubo sete e mantida com desflurano e oxigênio. A anestesia decorreu sem intercorrências, a cirurgia terminou em uma hora e 50 minutos. Não houve quaisquer complicações no pós-operatório imediato, durante a internação, nem deterioração do exame neurológico. A doente teve alta 20 dias depois. Discussão/Conclusão Há relatos de diminuição da resposta eletromiográfica e deterioração neurológica associadas ao propofol nesses doentes, razão para uso de etomidato. A metabolização hepática do rocurônio representava um risco e se optou pelo cisatracúrio. Conclui-se que o plano anestésico escolhido não teve qualquer interferência no curso da doença.

Avaliação morfofuncional do enxerto de túnica albugínea suína na cistoplastia em ratos / Morpho-fuctional evaluation of porcine tunica albuginea as a graft for cystoplasty in rats

O objetivo deste trabalho é avaliar o uso da túnica albugínea suína na cistoplastia em ratos, avaliando funcionalidade, capacidade de reparação do órgão e possibilidades de complicações. Foram selecionados 30 ratos Wistar, machos, de seis meses de idade, divididos em: um grupo teste (TA), em que os animais receberam o enxerto de túnica albugínea suína após a cistectomia parcial e um grupo controle (C), em que os animais sofreram somente a cistectomia parcial. Os animais pertencentes a ambos os grupos foram divididos igualmente em subgrupos de cinco animais cada, que sofreram eutanásia em sete, 28 e 42 dias de pós-operatório. Foi realizada uma análise macroscópica e, posteriormente, uma análise histopatológica da região da ferida cirúrgica. Aos sete e 28 dias, os animais pertencentes ao grupo C e ao grupo TA apresentaram urotelização, regeneração da lâmina própria e da musculatura, porém o grupo TA apresentou menores sinais inflamatórios e maior organização tecidual, principalmente com relação à formação das fibras musculares. Aos 42 dias de pós-operatório, ambos os grupos já apresentavam características histológicas normais. Concluiu-se que o enxerto de túnica albugínea suína obteve sucesso na regeneração da bexiga de ratos, mantendo a funcionalidade do órgão, sem rejeição, e favorecendo a migração celular.(AU)

The aim of this study is to evaluate porcine tunica albuginea as a graft for cystoplasty in rats, regarding bladder function, capacity and possible complications. 30 male Wistar rats with six monthes of age have been selected and separated into two different groups: A test group (TA) in which the animals received a tunica albuginea graft after partial cystectomy and a control group (C) in which partial cystectomy was performed, followed by bladder suture. In each group the animals were euthanized at seven, 28 and 42 days after surgery. Macroscopic and Histological analysis have been performed. At seven and 28 days after surgery the samples from both groups had urothelial lining upon a lamina propria and smooth muscle fibers in regeneration process. However, the TA group showed less inflammatory signs and more organized structure, mainly regarding the smooth muscle formation. At 42 days after surgery all groups showed a bladder wall structure qualitatively identical to the normal tissue. We could conclude that tunica albuginea graft is able to maintain bladder function and support cellular migration without any kind of rejection.(AU)

Small cell carcinoma of the bladder / Carcinoma de células pequenas de bexiga

Small cell carcinoma of the urinary bladder is an extremely aggressive and rare tumor. Even though small cell carcinoma most commonly arises from the lungs there are several reports of small cell carcinoma in extrapulmonary sites. Due to its low frequency there is no well-established management for this disease. We report the case of a 61 year-old man with small cell carcinoma of the bladder who underwent radical cystectomy following neoadjuvant chemotherapy. We also reviewed the literature for the optimal treatment strategy.

O carcinoma de células pequenas da bexiga urinária é um tumor extremamente agressivo e raro. Apesar desses tumores terem como sítio principal o pulmão, existem diversos relatos de carcinoma de pequenas células extrapulmonares. Pela baixa frequência, ainda não existe um tratamento bem estabelecido para essa neoplasia. Relatamos o caso de um homem de 61 anos de idade com carcinoma de células pequenas da bexiga urinária que foi submetido à quimioterapia neoadjuvante seguida de cistectomia radical. Fazemos ainda revisão na literatura em busca dos métodos de maior sucesso para o tratamento.

Cistectomia com reconstrução de neobexiga ortotópica ileal para tratamento de bexiga contraída após aplicação de bacilo de Calmette-Guérin intravesical / Cystectomy with orthotopic ileal neobladder reconstruction for treatment of bladder contracture after intravesical bacillus Calmette-Guerin therapy

O câncer de bexiga é um importante problema de saúde mundial, tanto pelas elevadas taxas de prevalência, quanto pelos custos relacionados ao tratamento. Desde a introdução da imunoterapia intravesical adjuvante com bacilo Calmette-Guérin, vem sendo observada diminuição na taxa de recorrência. As principais complicações são de pequeno porte e simples resolução a partir de medidas locais e orientações. A bexiga contraída, uma complicação local rara e grave, mas incapacitante em alguns casos, é observada principalmente em doentes com um programa de manutenção. Relatamos aqui o caso de um paciente masculino submetido a ressecção transuretral da bexiga por um carcinoma urotelial T1 de alto grau, que desenvolveu tal complicação durante tratamento com bacilo Calmette-Guérin, sendo portanto submetido à cistoprostatectomia com realização de neobexiga ortotópica ileal.

Bladder cancer is an important health problem worldwide due to high prevalence rates and costs related to treatment. A reduction in recurrence rates has been observed since the introduction of adjuvant intravesical immunotherapy with bacillus Calmette-Guerin. There are mild complications that are easily solved by local measures and orientations. Bladder contracture, a rare and severe local complication, in some cases leading to disability, is observed primarily in patients in a maintenance program. In this article we reported the case of a male patient who underwent transurethral resection of the bladder because of a high-grade T1 urothelial carcinoma and developed this complication during treatment with bacillus Calmette-Guerin. For this reason he was submitted to cystoprostatectomy with orthotopic ileal neobladder reconstruction.

Cistectomía radical por cáncer vesical en un hospital docente-asistencial: análisis de resultados perioperatorios / Radical cystectomy for bladder cancer in a state teaching hospital: analysis of perioperative outcomes

Introduction: A number of patients have been studied after undergoing Radical Cystectomy (RC) for bladder cancer, to review prognostic factors and analyze perioperative outcomes. A contemporary benchmark was established for future comparisons. Material and Methods: Retrospective study of 46 patients that underwent RC for bladder cancer between July 2003 and September 2012, assessing demographic characteristics, comorbidities, anesthetic risk and clinical status, interval between transurethral resection (TUR) and cystectomy, operative times, bleeding and transfusions, surgical technique, nutritional management, pathologic findings, hospital stay and complications. Complications were detailed by type and frequency and classified as early (within 30 days) or late. In addition, we used the Clavien-Dindo classification for reporting postoperative complications. Mortality rates at 30, 60 and 90 days after cystectomy were estimated. Results: Average patient age was 70 years (49-88) and mean ASA classification was 2.7. The average between TUR and cystectomy was 68.2 days (median = 57.5 days). Mean operative time for cutaneous ureterostomy was 194 minutes, 320 for ileal conduit and 342 for neobladder. 60.8 percent had pathological stage major than pT2 and 41 percent had nodal involvement. There were 19.5 percent of positive margins. The 23.9 percent had Clavien-Dindo postoperative complications grade 3 or 4. The 90-day global mortality was 17.3 percent. Conclusions: CR was associated with a high morbidity and mortality, which seems to be explained by an advanced stage of the disease and the high presence of poor prognostic factors.

Objetivos: Estudiamos una serie de pacientes sometidos a cistectomía radical (CR) por cáncer vesical para examinar factores pronósticos y analizar los resultados perioperatorios, estableciendo así un punto de referencia para futuras evaluaciones. Material y Método: Estudio retrospectivo de 46 pacientes sometidos a CR por cáncer vesical entre julio de 2003 y septiembre de 2012, evaluando características demográficas, comorbilidades, riesgo anestésico y condición clínica, lapso entre la resección transuretral (RTU) y la cistectomía, tiempos operatorios, sangrado y transfusiones, técnica quirúrgica utilizada, manejo nutricional, resultados anatomopatológicos, estada hospitalaria y complicaciones. Estas últimas fueron detalladas según tipo y frecuencia y catalogadas como precoces (durante los primeros 30 días) o tardías. Además, se utilizó la clasificación de Clavien-Dindo para reportar las complicaciones postoperatorias. Se estimaron las tasas de mortalidad a 30, 60 y 90 días post cistectomía. Resultados: El promedio de edad fue 70 años (49-88) y la media de la clasificación ASA fue 2,7. El promedio entre la RTU y la cistectomía fue 68,2 días. Los tiempos operatorios promedio fueron de 194 min la ureterostomía cutánea, 320 el conducto ileal y 342 la neovejiga. Un 60,8 por ciento tenía un pT > 2 y un 41 por ciento compromiso ganglionar. Hubo 19,5 por ciento de márgenes positivos. Un 23,9 por ciento tuvo complicaciones grado 3 ó 4 según Clavien-Dindo. La mortalidad global a 90 días fue 17,3 por ciento. Conclusiones: la CR se asoció a una elevada morbimortalidad, lo que parece explicarse por un estado avanzado de la enfermedad y por la alta presencia de factores de mal pronóstico.

Considerações anestésicas para cistectomia robótica: estudo prospectivo / Anesthetic considerations for robotic cystectomy: a prospective study / Consideraciones anestésicas para la cistectomía robótica:estudio prospectivo

Experiência e objetivos: a cistectomia robótica vem rapidamente se tornando parte do repertório cirúrgico de rotina para o tratamento do câncer de próstata. Nosso objetivo foi descrever os desafios respiratórios e hemodinâmicos e as complicações observadas em pacientes de cistectomia robótica. Pacientes: foram prospectivamente recrutados 16 pacientes tratados com cistectomia robótica entre dezembro de 2009 e janeiro de 2011. As medidas de desfecho primário foram monitoração não invasiva, monitoração invasiva e análise de gases sangüíneos feita nas posições supina (T0), Trendelenburg (T1), Trendelenburg + pneumoperitônio (T2), Trendelenburg antes da dessuflação (T3), Trendelenburg depois da dessuflacão (T4) e supina (T5). Resultados: houve diferencas significativas entre T0 - T1 e T0 - T2 com frequências cardíacas mais baixas. O valor médio para a pressão arterial em T1 foi significativamente mais baixo do que em T0. O valor da pressão venosa central foi significativamente mais elevado em T1, T2, T3 e T4 versus T0. Não foi observada diferença significativa no valor de PET-CO2 em qualquer ponto temporal, em comparação com T0. Também não foram notadas diferenças significativas na frequência respiratória em qualquer ponto temporal, em comparação com T0. Os valores médios de ƒ em T3, T4 e T5 foram significativamente mais elevados versus T0. A ventilação minuto média em T4 e T5 foi significativamente mais elevada versus T0. As pressões de platô e de pico médias em T1, T2, T3, T4 e T5 foram significativamente mais elevadas versus T0. Conclusões: embora a maioria dos pacientes geralmente tolere satisfatoriamente a cistectomia robótica e perceba os benefícios, os ...

Background and objectives: Robotic cystectomy is rapidly becoming a part of the standard surgical repertoire for the treatment of prostate cancer. Our aim was to describe respiratory and hemodynamic challenges and the complications observed in robotic cystectomy patients. Patients: Sixteen patients who underwent robotic surgery between December 2009 and January 2011 were prospectively enrolled. Main outcome measures were non-invasive monitoring, invasive monitoring and blood gas analysis performed at supine (T0), Trendelenburg (T1), Trendelenburg + pneumoperitoneum (T2), Trendelenburg-before desufflation (T3), Trendelenburg (after desufflation) (T4), and supine (T5) positions. Results: There were significant differences between T0 - T1 and T0 - T2 with lower heart rates. The mean arterial pressure value at T1 was significantly lower than T0. The central venous pressure value was significantly higher at T1, T2, T3, and T4 than at T0. There was no significant difference in the PET-CO2 value at any time point compared with T0. There were no significant differences in respiratory rate at any time point compared with T0. The mean ƒ values at T3, T4, and T5 were significantly higher than T0. The mean minute ventilation at T4 and T5 were significantly higher than at T0. The mean plateau pressures and peak pressures at T1, T2, T3, T4, and T5 were significantly higher than the mean value at T0. Conclusions: Although the majority of patients generally tolerate robotic cystectomy well and appreciate the benefits, anesthesiologists must consider the changes in the cardiopulmonary system that occur when patients are placed in Trendelenburg position, and when pneumoperitoneum is created. .

Antecedentes y objetivos: la cistectomía robótica se ha convertido rápidamente en parte del repertorio quirúrgico de rutina para el tratamiento del cáncer de próstata. Nuestro objetivo ha sido describir los retos respiratorios y hemodinámicos, junto con las complicaciones observadas en pacientes sometidos a cistectomía robótica. Pacientes: diesiséis pacientes tratados con cistectomía robótica entre diciembre de 2009 y enero de 2011 se reclutaron de forma prospectiva. Las medidas de resultado primario fueron la monitorización no invasiva, la monitorización invasiva y la gasometría sanguínea realizada en las posiciones supina (T0), Trendelenburg (T1), Trendelenburg + neumoperitoneo (T2), Trendelenburg antes del desinflado (T3), Trendelenburg después del desinflado (T4), y supina (T5). Resultados: hubo diferencias significativas entre T0-T1 y T0-T2 con frecuencias cardíacas más bajas. El valor medio para la presión arterial en T1 fue significativamente más bajo que en T0. El valor de la presión venosa central fue significativamente más elevado en T1, T2, T3, y T4 versus T0. No se observó diferencia significativa en el valor de PET-CO2 en ningún momento en comparación con T0. Tampoco se encontraron nunca diferencias significativas en la frecuencia respiratoria en comparación con T0. Los valores medios de ƒ en T3, T4, y T5 fueron significativamente más elevados versus T0. La ventilación minuto promedio en T4 y T5 fue significativamente más elevada versus T0. Las presiones de meseta y de pico promedios en T1, T2, T3, T4, y T5 fueron significativamente más elevadas versus T0. Conclusiones: aunque la mayoría de los pacientes generalmente tolere satisfactoriamente la cistectomía robótica y se dé cuenta de los beneficios, los anestesiólogos deben tener ...

Utilidad de la tomografía computarizada multidetector en la evaluación postoperatoria de cirugías de derivación urinaria / Usefulness of multidetector computed tomography in the postoperative evaluation of urinary diversion surgery

Las cirugías de derivación urinaria son procedimientos que cada vez son más frecuentes, ya que sus indicaciones no son sólo neoplásicas, siendo también útiles en el manejo de otras patologías. Debido a este incremento, no es infrecuente observar complicaciones secundarias, ya sean en el postoperatorio temprano (menos de 30 días después de la cirugía) o tardío (más de 30 días). Dentro de éstas tenemos alteraciones de la motilidad intestinal (íleo paralítico, obstrucción), fugas anastomóticas, colecciones líquidas (linfocele, urinoma, absceso), fístulas, herniación paraestomal, estenosis ureterales, litiasis y recurrencia tumoral. Dada la gran cantidad de técnicas quirúrgicas usadas en estos procedimientos, es importante conocer los cambios anatómicos resultantes, ocasionalmente de difícil valoración. La tomografía computarizada multidetector (TCMD) tiene gran utilidad en el estudio de estos pacientes, especialmente mediante las técnicas de reconstrucción multiplanar, representando adecuadamente las estructuras urinarias y extraurinarias afectadas, y sus relaciones con estructuras adyacentes, permitiendo identificarlas acertada y rápidamente.

Urinary diversion surgeries are procedures that are becoming more frequent, as their indications are not only neoplastic, being useful also in managing other diseases. Due to this increase, it is not uncommon to observe secondary complications, whether in the early postoperative period (less than 30 days after surgery) or later (more than 30 days). Within these are alterations in intestinal motility (paralytic ileus, blockage), anastomotic leaks, fluid collections (lymphocele, urinoma, abscess), fistulas, parastomal herniation, ureteral obstruction, urolithiasis and tumor recurrence. Given the large number of surgical techniques used in these procedures, it is important to know the resulting anatomical changes, occasionally difficult to evaluate. Multidetector computed tomography (MDCT) is of great use in the study of these patients, especially with multiplanar reconstruction techniques, adequately representing the affected urinary and extra-urinary structures, and their relationship to adjacent structures, enabling their accurate and quick identification.

Análisis de supervivencia en pacientes sometidos a cistectomía radical por cáncer vesical en un Hospital docente-asistencial / Analysis of survival in patients undergoing radical cystectomy forbladder cancer in a teaching Hospital

Examinar factores pronósticos y analizar la supervivencia en pacientes sometidos a cistectomía radical (CR) por cáncer vesical. MATERIAL Y MÉTODO: estudio de cohortes retrospectivo de 46 pacientes sometidos a CR por cáncer vesical entre julio de 2003 y septiembre de 2012, considerándose como variable dependiente la supervivencia y como variables independientes: las características demográficas, comorbilidades, riesgo anestésico, condición clínica, lapso entre la RTU y la cistectomía, derivación urinaria utilizada, resultados anatomopatológicos y complicaciones postoperatorias. Se analizó la supervivencia mediante Kaplan-Meier, elaborando curvas que fueron comparadas mediante el método de Mantel-Cox. Se efectuó un análisis de supervivencia a 2 años de la cistectomía, mediante regresión logística binaria multivariante. RESULTADOS: La media de la supervivencia global fue 31,8 meses (mediana = 12 meses) y la de la específica 38,2 meses (mediana = 16). La supervivencia global fue mayor en enfermos menores de 70 años, con función renal o albuminemia normales, ASA <3 y en quienes se elaboró una neovejiga. La supervivencia específica fue mayor en los pacientes con estadio tumoral (pT) <3, densidad ganglionar <20 por ciento, margen quirúrgico negativo, sin compromiso ganglionar o masa residual (R0) y en los sometidos a linfadenectomía. Los factores de riesgo para fallecer dentro de los primeros 2 años fueron edad sobre 69 años, ASA >2, pT >2 (OR 25), compromiso ganglionar, metástasis a distancia, masa residual y margen positivo. CONCLUSION: La infiltración local, la afectación ganglionar y una edad mayor a 69 años fueron los tres factores de riesgo más determinantes de un peor pronóstico.

To review prognostic factors and analyze the survival of patients treated with radical cystectomy (RC) for bladder cancer. MATERIALS AND METHODS: Retrospective cohort study of 46 patients underwent RC for bladder cancer between July 2003 and September 2012 was carried out, considering survival as the dependent variable and as independent variables the following: demographic characteristics, comorbidities, anesthetic risk, clinical condition, delay between transurethral resection (TUR) and cystectomy, urinary diversion performed, pathologic findings, and postoperative complications. A survival analysis using the Kaplan-Meier method was performed; as a result curves were obtained and compared using the Mantel-Cox test. A multivariate binary logistic regression was performed, and prognostic factors of survival at 2 years of cystectomy were evaluated. RESULTS: The median overall survival was 31.8 months (median 12 months) and specific overall survival was 38.2 months (median = 16). Overall survival was higher in patients younger than 70 years, with normal renal function and normal albumin, ASA minor than 3 and in those that a neobladder was developed. Specific survival was higher in patients with tumor stage (pT) <3, node density <20 percent, negative surgical margins, without lymph node involvement or residual mass (R0) and in those underwent to lymphadenectomy. Risk factors for death within the first 2 years were: age over 69 years, ASA> 2, pT> 2 (OR 25), nodal involvement, distant metastases, residual mass and positive margins. CONCLUSIONS: Local infiltration, lymph node involvement and age over 69 years were the three most crucial risk factors for a worse prognosis.